[1] |
Pirola C J, Sookoian S. The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis. Hepatology (Baltimore, Md), 2015, 62: 1742-1756.
|
[2] |
Cui J, Chen C H, Lo M T, et al. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology (Baltimore, Md), 2016, 64: 1547-1558.
|
[3] |
Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nature genetics, 2008, 40: 1461-1465.
|
[4] |
Sookoian S, Pirola C J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md), 2011, 53: 1883-1894.
|